Although in vivo probiotic bacteria do not come in direct contact with breast cancer cells, their beneficial effect in reducing tumor frequency was undisputably revealed and attributed to systemic immunomodulatory effects induced by LP in tumor tissue such as increased levels of CD4+T- and CD8+T-cells as well as reduced serum TNF concentrations [32]. The gene discussed is CD4; the disease is breast cancer.